Duke Telch
Analyst
J.P. Morgan
Equibles does not estimate personal net worth.
About Duke Telch
Duke Telch is recorded as Analyst at J.P. Morgan. Duke Telch has spoken on 1 earnings call across 1 company, most recently for Ultragenyx Pharmaceutical Inc. on November 3, 2026. The companies whose calls Duke Telch spoke on are classified in the Healthcare sector.
Duke Telch on recent calls
“You talked a bit about what you were seeing in the Wilson disease program, but could you walk us through your decision to discontinue it, please?”
Affiliation history
-
J.P. Morgan
Analyst
Transcript header (unverified)
Current